Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Social Buzz: Wallstreetbets Stocks Mostly Declining Pre-Bell Wednesday; Intuit, Strategy to Open Lower

Social Buzz: Wallstreetbets Stocks Mostly Declining Pre-Bell Wednesday; Intuit, Strategy to Open Lower

MT newswireMT newswire2026/08/26 10:35
06:35 AM EDT, 08/26/2026 (MT Newswires) -- The most-talked-about stocks in the Reddit subforum Wallstreetbets were mostly lower hours before Wednesday's opening bell. Broadcom (AVGO) was 0.4% higher in pre-bell activity, swinging from a 0.6% decline at Tuesday's close. Nvidia (NVDA) was up 0.2% hours before market open, after a 2.2% increase from the previous session. Intuit (INTU) fell 12.6% pre-bell, after closing Tuesday with a 3.4% decline. The company issued outlook for fiscal Q1 and 2027 below market expectations. Strategy (MSTR) was down 1.4% premarket, swinging from a 3.4% rise at Tuesday's close. Dick's Sporting Goods (DKS) was 1.1% lower in premarket activity, following a 28% fall at Tuesday's close. The company posted a decline in fiscal Q2 non-GAAP earnings and cut its fiscal 2026 outlook. Sandisk (SNDK) declined by nearly 1% pre-bell, after closing Tuesday with a 0.8% fall. Micron Technology (MU) was down 0.8% premarket, swinging from a 2.5% increase at Tuesday's close. Moderna (MRNA) fell 0.5% in pre-bell hours, after a 14.4% rise from the previous session.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.